ConductScience.org, home

Paper35565286

Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.

Blanco M and 4 others. Cancers (Basel), 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma. Papers, record 35565286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35565286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.65
iCite
Revised in PubMed
2022-07-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blanco MMariola
2Collazo-Lorduy AAna
3Yanguas-Casás NNataliahttps://orcid.org/0000-0003-4368-0176
4Calvo VVirginiahttps://orcid.org/0000-0002-3503-4847
5Provencio MMariano

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121785430Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.Nat Med2011https://conductscience.org/library/papers/21785430PubMed
231112476Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.J Clin Oncol2019https://conductscience.org/library/papers/31112476PubMed
324617454A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.Br J Haematol2014https://conductscience.org/library/papers/24617454PubMed
430742566DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.J Clin Oncol2019https://conductscience.org/library/papers/30742566PubMed
532540726Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.Int Immunopharmacol2020https://conductscience.org/library/papers/32540726PubMed
61956400Intraclonal generation of antibody mutants in germinal centres.Nature1991https://conductscience.org/library/papers/1956400PubMed
724332512Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.Lancet Oncol2014https://conductscience.org/library/papers/24332512PubMed
824634660Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.Front Physiol2014https://conductscience.org/library/papers/24634660PubMed
931187532Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease.Hematol Oncol2019https://conductscience.org/library/papers/31187532PubMed
1017908969A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.Clin Cancer Res2007https://conductscience.org/library/papers/17908969PubMed
1122740445Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas.Blood2012https://conductscience.org/library/papers/22740445PubMed
1224727328Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Clin Cancer Res2014https://conductscience.org/library/papers/24727328PubMed
1318086798High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.J Clin Oncol2008https://conductscience.org/library/papers/18086798PubMed
1419636063A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.Blood2009https://conductscience.org/library/papers/19636063PubMed
157727781Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.Blood1995https://conductscience.org/library/papers/7727781PubMed
1634209703Macrophage Polarization States in the Tumor Microenvironment.Int J Mol Sci2021https://conductscience.org/library/papers/34209703PubMed
1728977875Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma.Oncotarget2017https://conductscience.org/library/papers/28977875PubMed
1827451390Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.Lancet Oncol2016https://conductscience.org/library/papers/27451390PubMed
1931481504A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma.Clin Cancer Res2019https://conductscience.org/library/papers/31481504PubMed
2030380386CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.N Engl J Med2018https://conductscience.org/library/papers/30380386PubMed

See all 80 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42884057Intrafollicular PAI-1 Expression Is Associated with Absence of Histological Transformation During Long-Term Follow-Up in Follicular Lymphoma.Int J Mol Sci2026https://conductscience.org/library/papers/42884057PubMed
42046736Advancements in Nanomedicine for Precision Management of Lymphoma: Mechanisms, Diagnostics, and Therapeutic Strategies.Int J Nanomedicine2026https://conductscience.org/library/papers/42046736PubMed
41227317Sequencing Cellular Therapies in the Management of Follicular Lymphoma.Cells2025https://conductscience.org/library/papers/41227317PubMed
40360644Identification of the histologic transformation of follicular lymphoma using super-resolution microcirculation imaging.Sci Rep2025https://conductscience.org/library/papers/40360644PubMed
40015744Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment.Biomark Med2025https://conductscience.org/library/papers/40015744PubMed
39085126Mechanisms of lymphoma-stromal interactions focusing on tumor-associated macrophages, fibroblastic reticular cells, and follicular dendritic cells.J Clin Exp Hematop2024https://conductscience.org/library/papers/39085126PubMed
38115544Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways.Mol Oncol2024https://conductscience.org/library/papers/38115544PubMed
37681500Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis.Oncol Rep2023https://conductscience.org/library/papers/37681500PubMed

Download CSV of cited by

Genes95

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
BTLA151888PubTator's text mininghttps://conductscience.org/library/genes/151888NCBI Gene
CARD1184433PubTator's text mininghttps://conductscience.org/library/genes/84433NCBI Gene
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CCL176361PubTator's text mininghttps://conductscience.org/library/genes/6361NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CCL226367PubTator's text mininghttps://conductscience.org/library/genes/6367NCBI Gene
CCL46351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD1C911PubTator's text mininghttps://conductscience.org/library/genes/911NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene

See all 95 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35565286

GET https://conductscience.org/api/papers/v1/35565286/references?page=2